Tatlı, A. M. Et Al. 2014. Treatment with capecitabine + bevacizumab following induction treatment with FOLFIRI + bevacizumab in metastatic colorectal carcinoma.. International journal of clinical and experimental medicine , vol.7, no.8 , 2191-6.

Tatlı, A. M., Coşkun, H. Ş., Uysal, M., Arslan, D., Sezgin Göksu, S., Güenay Gündüz, S., ... Cakal, S.(2014). Treatment with capecitabine + bevacizumab following induction treatment with FOLFIRI + bevacizumab in metastatic colorectal carcinoma.. International journal of clinical and experimental medicine , vol.7, no.8, 2191-6.

Tatlı, ALİ Et Al. "Treatment with capecitabine + bevacizumab following induction treatment with FOLFIRI + bevacizumab in metastatic colorectal carcinoma.," International journal of clinical and experimental medicine , vol.7, no.8, 2191-6, 2014

Tatlı, ALİ M. Et Al. "Treatment with capecitabine + bevacizumab following induction treatment with FOLFIRI + bevacizumab in metastatic colorectal carcinoma.." International journal of clinical and experimental medicine , vol.7, no.8, pp.2191-6, 2014

Tatlı, A. M. Et Al. (2014) . "Treatment with capecitabine + bevacizumab following induction treatment with FOLFIRI + bevacizumab in metastatic colorectal carcinoma.." International journal of clinical and experimental medicine , vol.7, no.8, pp.2191-6.

@article{article, author={ALİ MURAT TATLI Et Al. }, title={Treatment with capecitabine + bevacizumab following induction treatment with FOLFIRI + bevacizumab in metastatic colorectal carcinoma.}, journal={International journal of clinical and experimental medicine}, year=2014, pages={2191-6} }